RxDoctor Payments Data

Sandra Anderson

Family · Venice, FLNPI 1285988121

Payments from drug & device makers

$846in general payments, 2019–2025

Across 13 payments — averaging $65.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Terumo Cardiovascular Systems Corporation$601
  • Novo Nordisk$51
  • Smith+Nephew$39
  • Novartis$24
  • Atricure, Inc.$20
  • Johnson & Johnson$19
  • plus $92 from 6 others

What the payments were for

  • Travel & lodging$60171%
  • Food & beverage$24529%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$846 in reported general payments places this provider in the 65th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$161,076
Medicare patients
593
Services billed
2,175

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban140$156,759
EntrestoSacubitril/Valsartan33$58,699
JardianceEmpagliflozin36$51,636
XareltoRivaroxaban31$40,870
FarxigaDapagliflozin Propanediol21$30,619
Metoprolol Succinate346$4,415
Ranolazine ErRanolazine34$3,970
Bumetanide135$3,339
Diltiazem 24hr Er (Cd)Diltiazem Hcl70$2,159
Amiodarone Hcl16$2,023
Midodrine Hcl20$1,850
Losartan Potassium121$1,618
Ezetimibe36$1,297
Digoxin53$1,246
Rosuvastatin Calcium103$1,241

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$16$156,759140 claims
NovartisEntresto$24$58,69933 claims
Johnson & JohnsonXarelto$19$40,87031 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 14,618 family providers in Florida.

Other family in Venice

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →